Dr. Joseph Peter Bouvier , MD
Ophthalmology • Springfield, MA
275 Bicentennial Hwy Ste 101
Springfield, MA 011181965
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on August 5, 2006; this date does not establish years in practice.
-
Published CMS data list 3,990 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 92014 — Established patient complete exam of visual system: 1,216 service units.
- 92133 — Imaging of optic nerve: 565 service units.
- 92012 — Established patient problem focused exam of visual system: 505 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 18 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 4,251 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Latanoprost — 771 prescription fills, including refills.
- Ketorolac Tromethamine — 533 prescription fills, including refills.
- Dorzolamide-Timolol (Dorzolamide Hcl/Timolol Maleat) — 419 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 42 records in the table · Guide: How to read Medicare Part D prescriber data
-
Fewer Medicare Part B services than 70% of clinicians listed under Ophthalmology in Springfield, MA (2024, 12 clinicians with data). Median for this group: 7,071. Middle half: 3,838 to 24,877.
More Medicare Part B services than 75% of clinicians listed under Ophthalmology in Massachusetts (2024, 482 clinicians with data). Median for this group: 1,836. Middle half: 620 to 3,509.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 2,918 in 2020 to 3,990 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
275 Bicentennial Hwy Ste 101
Springfield, MA 011181965
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
NPPES lists 1 additional practice-address record in Longmeadow, MA. See the list
Source: CMS NPPES NPI Registry, practice location records; release date unavailable.
CMS Doctors and Clinicians lists 1 group name: Andrew S Jusko Md Pc. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
Columbia University College Of Physicians And Surgeons
1994
What Public CMS Data Show
Ophthalmology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
1,330 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $527,392 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $371,966 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
6,243 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$518,991 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $424.51 across 17 records.
By nature of payment
- Food and Beverage: $424.51 across 17 records.
Reporting-company totals (3 largest of 7)
- ABBVIE INC.: $154.56 across 6 records.
- Glaukos Corporation: $73.57 across 3 records.
- Tarsus Pharmaceuticals, Inc.: $58.31 across 2 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
32 years (graduated 1994)
CMS Doctors and Clinicians data list 1994 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Bouvier has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Bouvier as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Springfield and Massachusetts
Billing and prescribing volume is not a quality rating.
Medicare Part B services
Fewer Medicare Part B services than 70% of clinicians listed under Ophthalmology in Springfield, MA (2024, 12 clinicians with data). Median for this group: 7,071. Middle half: 3,838 to 24,877.
More Medicare Part B services than 75% of clinicians listed under Ophthalmology in Massachusetts (2024, 482 clinicians with data). Median for this group: 1,836. Middle half: 620 to 3,509.
Medicare-allowed amount
Close to the middle for clinicians listed under Ophthalmology in Springfield, MA (2024, 12 clinicians with data). Median for this group: $597,301. Middle half: $458,560 to $2,843,201.
A higher Medicare-allowed amount than 80% of clinicians listed under Ophthalmology in Massachusetts (2024, 482 clinicians with data). Median for this group: $194,367. Middle half: $57,908 to $416,629.
Paid by Medicare
Close to the middle for clinicians listed under Ophthalmology in Springfield, MA (2024, 12 clinicians with data). Median for this group: $431,741. Middle half: $334,497 to $2,231,796.
A higher Medicare payment amount than 80% of clinicians listed under Ophthalmology in Massachusetts (2024, 482 clinicians with data). Median for this group: $144,463. Middle half: $40,965 to $304,911.
Medicare Part D prescriptions
More Part D prescriptions than 70% of clinicians listed under Ophthalmology in Springfield, MA (2024, 12 clinicians with data). Median for this group: 1,592. Middle half: 553 to 4,285.
More Part D prescriptions than 90% of clinicians listed under Ophthalmology in Massachusetts (2024, 517 clinicians with data). Median for this group: 764. Middle half: 219 to 2,063.
Part D drug cost
A higher Part D drug cost than 70% of clinicians listed under Ophthalmology in Springfield, MA (2024, 12 clinicians with data). Median for this group: $152,725. Middle half: $13,557 to $532,270.
A higher Part D drug cost than 90% of clinicians listed under Ophthalmology in Massachusetts (2024, 517 clinicians with data). Median for this group: $61,248. Middle half: $7,840 to $214,090.
17 active clinicians are listed under Ophthalmology with a practice address in Springfield, MA (792 in Massachusetts).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Springfield
0% of these 17 clinicians have the CMS telehealth indicator.
64.7% of these 17 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 37% from 2,918 in 2020 to 3,990 in 2024.
- 2020: 2,918
- 2021: 3,809
- 2022: 4,072
- 2023: 3,677
- 2024: 3,990
-
Medicare-allowed amount
Medicare-allowed amount increased 27% from $415,329 in 2020 to $527,392 in 2024.
- 2020: $415,329
- 2021: $548,517
- 2022: $567,647
- 2023: $477,049
- 2024: $527,392
-
Paid by Medicare
Paid by Medicare increased 20% from $308,814 in 2020 to $371,966 in 2024.
- 2020: $308,814
- 2021: $409,935
- 2022: $415,150
- 2023: $349,051
- 2024: $371,966
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 97% from 2,159 in 2020 to 4,251 in 2024.
- 2020: 2,159
- 2021: 2,602
- 2022: 2,951
- 2023: 3,093
- 2024: 4,251
-
30-day fills
30-day fills increased 74% from 3,581 in 2020 to 6,243 in 2024.
- 2020: 3,581
- 2021: 4,345
- 2022: 5,089
- 2023: 5,379
- 2024: 6,243
-
Part D drug cost
Part D drug cost increased 40% from $370,809 in 2020 to $518,991 in 2024.
- 2020: $370,809
- 2021: $504,990
- 2022: $589,504
- 2023: $597,439
- 2024: $518,991
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $846.04 in 2021 to $424.51 in 2025.
- 2021: $846.04
- 2022: $882.54
- 2023: $855.12
- 2024: $1,438.70
- 2025: $424.51
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 17 records totaling $424.51.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
DURYSTA | General | $33.45 |
| Tarsus Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
XDEMVY | General | $31.86 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
DURYSTA | General | $31.33 |
| Dompe US, Inc. |
Food and Beverage
In-kind items and services
|
OXERVATE | General | $29.65 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
DURYSTA | General | $29.27 |
| Dompe US, Inc. |
Food and Beverage
In-kind items and services
|
OXERVATE | General | $27.65 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
DURYSTA | General | $27.42 |
| Glaukos Corporation |
Food and Beverage
Cash or cash equivalent
|
iDoseTR | General | $27.07 |
| Tarsus Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
XDEMVY | General | $26.45 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
DURYSTA | General | $25.75 |
| Glaukos Corporation |
Food and Beverage
Cash or cash equivalent
|
iDoseTR | General | $24.00 |
| Glaukos Corporation |
Food and Beverage
Cash or cash equivalent
|
iStent infinite | General | $22.50 |
| Thea Pharma Inc. |
Food and Beverage
In-kind items and services
|
IYUZEH | General | $22.10 |
| Bausch & Lomb Americas Inc. |
Food and Beverage
In-kind items and services
|
VYZULTA | General | $20.95 |
| Bausch & Lomb Americas Inc. |
Food and Beverage
In-kind items and services
|
XIIDRA | General | $19.72 |
| SUN PHARMACEUTICAL INDUSTRIES INC. |
Food and Beverage
In-kind items and services
|
Cequa | General | $18.00 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
DURYSTA | General | $7.34 |
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
92014
Established patient complete exam of visual system
|
1,216 | 1,015 | $225.06 | $129.47 |
|
92133
Imaging of optic nerve
|
565 | 537 | $100.00 | $37.11 |
|
92012
Established patient problem focused exam of visual system
|
505 | 368 | $190.00 | $91.38 |
|
92134
Imaging of retina
|
258 | 237 | $100.00 | $41.08 |
|
92136
Measurement of corneal curvature and depth of eye
|
237 | 143 | $94.62 | $40.05 |
|
92004
New patient complete exam of visual system
|
224 | 224 | $250.00 | $152.86 |
|
66984
Removal of cataract with insertion of prosthetic lens
|
220 | 123 | $1650.00 | $548.38 |
|
92083
Exam of visual field with extended testing
|
208 | 199 | $95.00 | $65.66 |
|
76514
Ultrasound scan of cornea to determine thickness
|
137 | 137 | $32.00 | $10.83 |
|
66821
Removal of recurring cataract in lens capsule using a laser
|
122 | 92 | $533.61 | $340.55 |
|
92025
Ct scan of cornea
|
87 | 76 | $96.00 | $37.38 |
|
65855
Laser repair to improve eye fluid flow
|
72 | 60 | $530.00 | $206.25 |
|
66761
Creation of eye fluid drainage tracts in iris using a laser, per session
|
35 | 20 | $766.00 | $309.82 |
|
92020
Exam of the internal drainage system of eye
|
26 | 25 | $70.00 | $28.04 |
|
66982
Complex removal of cataract with insertion of prosthetic lens
|
24 | 19 | $2000.00 | $750.44 |
|
68320
Repair of eyelid lining with graft from external eye
|
21 | 20 | $2590.67 | $963.54 |
|
68440
Snip incision of tear duct at inner corner of eye
|
21 | 20 | $400.76 | $133.54 |
|
92250
Photography of the retina
|
12 | 11 | $150.00 | $37.99 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Latanoprost | Latanoprost | 771 | 31,073 | $8,376.01 | 174 |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 533 | 21,736 | $9,347.53 | 339 |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 419 | 23,179 | $6,392.36 | 125 |
| Prednisolone Acetate | Prednisolone Acetate | 405 | 10,405 | $12,394.02 | 278 |
| Tobramycin-Dexamethasone | Tobramycin/Dexamethasone | 342 | 7,629 | $13,555.12 | 196 |
| Timolol Maleate | Timolol Maleate | 257 | 13,022 | $3,243.83 | 72 |
| Lumigan | Bimatoprost | 157 | 6,399 | $58,848.05 | 51 |
| Brimonidine Tartrate | Brimonidine Tartrate | 142 | 6,310 | $6,550.80 | 35 |
| Dorzolamide Hcl | Dorzolamide Hcl | 134 | 7,028 | $2,368.17 | 39 |
| Restasis | Cyclosporine | 128 | 6,690 | $129,811.11 | 57 |
| Loteprednol Etabonate | Loteprednol Etabonate | 101 | 3,473 | $23,555.82 | 51 |
| Moxifloxacin | Moxifloxacin Hcl | 84 | 1,850 | $1,445.81 | 33 |
| Cyclosporine | Cyclosporine | 67 | 4,380 | $31,221.46 | 37 |
| Neomycin-Polymyxin-Dexameth | Neomycin/Polymyxin B/Dexametha | 58 | 1,002 | $778.31 | 43 |
| Valacyclovir | Valacyclovir Hcl | 47 | 2,940 | $2,168.96 | 16 |
| Xiidra | Lifitegrast | 47 | 2,250 | $50,974.50 | 23 |
| Rocklatan | Netarsudil Mesylat/Latanoprost | 43 | 1,293 | $17,263.85 | 12 |
| Erythromycin | Erythromycin Base | 37 | 369 | $591.32 | 25 |
| Miebo | Perfluorohexyloctane/Pf | 36 | 1,234 | $27,712.34 | 14 |
| Vyzulta | Latanoprostene Bunod | 33 | 1,329 | $13,758.32 | 13 |
| Brimonidine Tartrate-Timolol | Brimonidine Tartrate/Timolol | 32 | 1,189 | $3,498.33 | — |
| Fluorometholone | Fluorometholone | 29 | 985 | $2,398.48 | 12 |
| Simbrinza | Brinzolamide/Brimonidine Tart | 28 | 1,270 | $6,405.02 | — |
| Combigan | Brimonidine Tartrate/Timolol | 27 | 1,355 | $16,333.78 | — |
| Travoprost | Travoprost | 27 | 975 | $3,159.68 | — |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2022-10-05NUCC Taxonomy Code: 207W00000X
An ophthalmologist has the knowledge and professional skills needed to provide comprehensive eye and vision care. Ophthalmologists are medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, an ophthalmologist prescribes vision services, including glasses and contact lenses.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - OPHTHALMOLOGY
I20051025000182
MA
3779516513
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Andrew S Jusko Md Pc
299 Carew St, Springfield, MA 011042360
Phone: 4137361833
Secondary Practice Locations
809 Williams St
Longmeadow, MA 011062060
Phone: 4137543808
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Optometrist
Doctor of Optometry
Ophthalmology
Doctor of Medicine (M.D.)
Optometrist
Doctor of Optometry
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 275 BICENTENNIAL HWY STE 101, SPRINGFIELD, MA 011181965 (Tel: 4137833100)
Registered at 275 BICENTENNIAL HWY STE 101, SPRINGFIELD, MA 011181965 (Tel: 4137833100)
NPI status registered as active in NPPES database
Registered at 275 BICENTENNIAL HWY, SPRINGFIELD, MA 011181900 (Tel: 4137833100)
Registered at 275 BICENTENNIAL HWY, SPRINGFIELD, MA 011181900 (Tel: 4137833100)
Recorded as JOSEPH BOUVIER, M.D.
Ophthalmology (license number reported to NPPES: MA 226532)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Ophthalmology Specialists in Springfield
- Dr. Raymond Magauran, MD
- Dr. Steven Berger, MD
- Dr. Andrew Jusko, MD
- Dr. David Lally, MD
- Dr. Hari Mylvaganam, MD
- Dr. John Papale, MD
Mailing Address
275 Bicentennial Hwy Ste 101
Springfield, MA 011181965
Phone: 4137833100